A practical chemoenzymatic process to access (R)-quinuclidin-3-ol on scale

This publication has 12 references indexed in Scilit:

• There's No Industrial Biocatalyst Like Hydrolase: Development of Scalable Enantioselective Processes Using Hydrolytic Enzymes¹
  Organic Process Research & Development, 2003
• Chemoenzymatic Approach toward the Pure Enantiomers of 2-Methyl-1,3-propanediol Mono(p-Methoxybenzyl Ether)
  Advanced Synthesis & Catalysis, 2001
• Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man
  Xenobiotica, 2000
• Controlled racemization of optically active organic compounds: Prospects for asymmetric transformation
  Tetrahedron, 1997
• (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
  Neuroscience Letters, 1989
• Enantiospecific synthesis of S-quinuclidinol from D-glucose: A strategy for the synthesis of chiral quinuclidines.
  Tetrahedron Letters, 1986
• Enzymatic resolution and cholinergic properties of (±)3-quinuclidinol derivatives
  Life Sciences, 1977
• Preparation of (+)‐3‐Quinuclidinol
  Israel Journal of Chemistry, 1971
• Antispasmodics. II. Esters of Basic Bicyclic Alcohols^*
  Journal of the American Chemical Society, 1952
• Antispasmodics. I. Bicyclic Basic Alcohols^*
  Journal of the American Chemical Society, 1952